- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Jon Hudson, MEDTHINK COMMUNICATIONS
Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact.
Jon Hudson
VICE PRESIDENT OF MEDIA AND DIGITAL SERVICES | MEDTHINK COMMUNICATIONS
Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact. There's an immediate short term savings, but the long term ROI suffers because the lack of visibility may further depress sales and reduce market share. Consistency of messaging is lost during times of relative silence, and companies must spend extra to regain their presence in the market once the economy brightens.
Jon Hudson
In fact, recessions are a time to find great deals. Publishers are more aggressive with rates and offer better positions and integrated campaigns for less dollars. Competitors are likely pulling back on their advertising. There is less clutter and noise in the marketplace and more opportunity for your company to stand out and carve a niche for itself.
If the decision makers can't be convinced that recessions present an opportunity, then it's time to integrate new technology that creates efficiencies, and saves time and money.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
